Monthly Archives: August 2023

Pope Francis and Rhodes University’s Institute for Nanotechnology Innovation Director,Tebello Nyokong

Leave a reply

I’d never heard of the Catholic Church’s Pontifical Academy of Sciences before this July 10, 2023 Rhodes University (South Africa) press release,

Rhodes University’s Institute for Nanotechnology Innovation Director, Distinguished Professor Tebello Nyokong, has been appointed to the Pontifical Academy of Sciences. As the head of the Catholic Church, the bishop of Rome and sovereign of the Vatican City State, Pope Francis appointed Professor Nyokong to the Academy.  

The Academy was founded in 1603 after a period of vicissitudes and was radically reformed by Pope Pius XI in 1936. The aim of the Academy is to promote the progress of mathematical, physical, and natural sciences and the study of epistemological problems relating thereto. The Academy chooses candidates for a seat in the Academy based on their eminent original scientific studies and their acknowledged moral personality, without any ethnic or religious discrimination. They are nominated for life by the sovereign act of the Pope.

Professor Nyokong said that when she first received the communiqué from the Pope, she deleted the correspondence, thinking it was spam. “Who receives an email from the Pope? I am not even catholic, so this came as a surprise for me,” she said. Only after receiving a call enquiring whether she had received the correspondence did she realise it was legit.

“It’s a great honour indeed. I will be travelling to the Vatican in 2024. How does the Pope even know me? I do not even know, but it means there is something holy about the work my students and I are doing,” said Professor Nyokong.

Pontifical Academy of Sciences Chancellor, Peter Kodwo Appiah Turkson, said: “Pope Francis will bestow on Professor Nyokong the insignia of her appointment during a Solemn Pontifical Audience at the next Plenary Session in October 2024.”

Professor Nyokong is researching a new cancer diagnosis and treatment methodology called photo-dynamic therapy, which is an alternative to chemotherapy. The new therapy is based on using a dye, which is used to colour blue denim clothing, and which is inert and harmless by itself but can be activated by exposure to a red laser beam. 

She is celebrated worldwide for the outstanding work she and her team continue to do. She has five honorary degrees including from her alma mater McMaster University in Ontario, Canada; University of South Africa (UNISA); Walter Sisulu University; the University of KwaZulu-Natal and another alma mater, Western University in Ontario, Canada.

Professor Nyokong is an honorary fellow of the Royal Society of Chemistry, and a  Fellow of the Royal Society. Rhodes University Vice-Chancellor congratulated Professor Nyokong. “We are incredibly proud of Distinguished Professor Nyokong, and we congratulate her on this huge recognition. This recognition is fitting for someone of Professor Nyokong’s calibre. Her many years of ground-breaking intellectual contribution, hard work, dedication, and commitment to this research-intensive University do not go unnoticed. She has and continues to contribute to our vision of being foremost in the generation and advancement of locally-responsive and globally-engaged knowledge dedicated to creating a just and sustainable world,” concluded Professor Mabizela [Dr Sizwe Mabizela].

Congratulations to Professor Tebello Nyokong!

You can find the Pontifical Academy of Sciences here. In addition to learning about a new ‘science’ agency and finding out the Catholic Church is aware of nanotechnology, I received another surprise on reading the Rhodes University press release in its entirety: Professor Nyokong has two Canadian connections (or alma maters).

Single chip mimics human vision and memory abilities

Leave a reply

A June 15, 2023 RMIT University (Australia) press release (also on EurekAlert but published June 14, 2023) announces a neuromorphic (brainlike) computer chip, which mimics human vision and ‘creates’ memories,

Researchers have created a small device that ‘sees’ and creates memories in a similar way to humans, in a promising step towards one day having applications that can make rapid, complex decisions such as in self-driving cars.

The neuromorphic invention is a single chip enabled by a sensing element, doped indium oxide, that’s thousands of times thinner than a human hair and requires no external parts to operate.

RMIT University engineers in Australia led the work, with contributions from researchers at Deakin University and the University of Melbourne.

The team’s research demonstrates a working device that captures, processes and stores visual information. With precise engineering of the doped indium oxide, the device mimics a human eye’s ability to capture light, pre-packages and transmits information like an optical nerve, and stores and classifies it in a memory system like the way our brains can.

Collectively, these functions could enable ultra-fast decision making, the team says.

Team leader Professor Sumeet Walia said the new device can perform all necessary functions – sensing, creating and processing information, and retaining memories – rather than relying on external energy-intensive computation, which prevents real-time decision making.

“Performing all of these functions on one small device had proven to be a big challenge until now,” said Walia from RMIT’s School of Engineering.

“We’ve made real-time decision making a possibility with our invention, because it doesn’t need to process large amounts of irrelevant data and it’s not being slowed down by data transfer to separate processors.”

What did the team achieve and how does the technology work?

The new device was able to demonstrate an ability to retain information for longer periods of time, compared to previously reported devices, without the need for frequent electrical signals to refresh the memory. This ability significantly reduces energy consumption and enhances the device’s performance.

Their findings and analysis are published in Advanced Functional Materials.

First author and RMIT PhD researcher Aishani Mazumder said the human brain used analog processing, which allowed it to process information quickly and efficiently using minimal energy.

“By contrast, digital processing is energy and carbon intensive, and inhibits rapid information gathering and processing,” she said.

“Neuromorphic vision systems are designed to use similar analog processing to the human brain, which can greatly reduce the amount of energy needed to perform complex visual tasks compared with today’s technologies

What are the potential applications?

The team used ultraviolet light as part of their experiments, and are working to expand this technology even further for visible and infrared light – with many possible applications such as bionic vision, autonomous operations in dangerous environments, shelf-life assessments of food and advanced forensics.

“Imagine a self-driving car that can see and recognise objects on the road in the same way that a human driver can or being able to able to rapidly detect and track space junk. This would be possible with neuromorphic vision technology.”

Walia said neuromorphic systems could adapt to new situations over time, becoming more efficient with more experience.

“Traditional computer vision systems – which cannot be miniaturised like neuromorphic technology – are typically programmed with specific rules and can’t adapt as easily,” he said.

“Neuromorphic robots have the potential to run autonomously for long periods, in dangerous situations where workers are exposed to possible cave-ins, explosions and toxic air.”

The human eye has a single retina that captures an entire image, which is then processed by the brain to identify objects, colours and other visual features.

The team’s device mimicked the retina’s capabilities by using single-element image sensors that capture, store and process visual information on one platform, Walia said.

“The human eye is exceptionally adept at responding to changes in the surrounding environment in a faster and much more efficient way than cameras and computers currently can,” he said.

“Taking inspiration from the eye, we have been working for several years on creating a camera that possesses similar abilities, through the process of neuromorphic engineering.” 

Here’s a link to and a citation for the paper,

Long Duration Persistent Photocurrent in 3 nm Thin Doped Indium Oxide for Integrated Light Sensing and In-Sensor Neuromorphic Computation by Aishani Mazumder, Chung Kim Nguyen, Thiha Aung, Mei Xian Low, Md. Ataur Rahman, Salvy P. Russo, Sherif Abdulkader Tawfik, Shifan Wang, James Bullock, Vaishnavi Krishnamurthi. Advanced Functional Materials DOI: https://doi.org/10.1002/adfm.202303641 First published: 14 June 2023

This paper is open access.

Frog pants?

Leave a reply

How would you go about tracking these frogs?

Six images of tiny frogs wearing little plastic trackers attached to wire harnesses on their back legs.
Researchers have fitted tiny trackable radio-pants to three species of South American frogs to test their ability to navigate through the rainforest. (Submitted by Andrius Pašukonis)

You can see how tiny they are when you compare one of the frogs to a leaf visible in one of the images (top left or top right).

The answer to the question, as you may have guessed, are frog pants (or G-strings).

Sheena Goodyear’s June 13, 2023 article for the CBC’s (Canadian Broadcasting Corporation) As It Happens radio show explores the question and the research and includes an embedded 6:20 radio interview with researcher, Andrius Pašukonis,

How do you track a bunch of teeny-weeny frogs across the vast rainforests of South America? By putting teeny-weeny trackers on their teeny-weeny underwear, of course.

Biologist Andrius Pašukonis and his colleagues wanted to study the navigational capabilities of poisonous frogs that are too small for most animal tracking devices.

So he designed a Speedo-like harness that wraps around their back legs and props a tiny radio tracker on their backsides. The research team dubbed the invention “frog pants” — though Pašukonis says that’s “a bit of a misnomer.”

“My French colleagues like to call it a telemetric G-string,” Pašukonis, a senior scientist at Lithuania’s Vilnius University, told As It Happens host Nil Köksal.

“It’s a lot of fine motor skills and a lot of practice in handling tiny frogs and sewing little frog harnesses. But we go find them in the rainforest, and we catch them, and we put the tags on.”

My favourite part is “… sewing little frog harnesses.” Note: The following video features a commercial and then, moves onto a 2:22 interview,

More from Goodyear’s June 13, 2023 article, Note: A link has been removed,

Pašukonis was a PhD student at the University of Vienna when he first started experimenting with the frog pants design, and later put it to use while working as a postdoctoral fellow at Stanford University in California.

He and is colleagues used the tracker pants to study the spatial skills of three frog species that range from three to five centimetres in length — diablito poison frogs in Ecuador, and brilliant-thighed poison frogs and dyeing poison frogs in French Guiana. The findings were published late last year in the journal e-Life [sic].

“The only way to study movements of animals is to be able to track them and follow them around, which nobody has managed to do or even tried to do with these tiny, tiny frogs in the rainforest,” he said.

“So that became my goal and challenge, where I spent a good part of my PhD trying different versions of different tags and different attachment methods, trial and error, to finally get to be able to put tags on and track them and study their behaviour.”

The frogs, he admits, didn’t particularly like the pants. But they didn’t seem to mind too much, and the team removed the trackers after four to six days. 

“Like any animal, they might scratch a little bit afterwards … like a dog with a new collar,” he said. “And then they just go on with their business.”

…

Other scientists have tried to track tiny frogs, from Goodyear’s June 13, 2023 article, Note: Links have been removed,

The design caught the eye of Richard Essner, a biologist at Southern Illinois University Edwardsville who studies animal locomotion, and has a particular interest in little frogs.

“Tracking small frogs with radio telemetry is not an easy thing to do,” Essner, who wasn’t involved in the Stanford research, told CBC in an email. 

About a decade ago, he says his lab attempted to use radio telemetry to track the movement of the threatened Illinois chorus frog using a transmitter attached via an elastic belt around the waist.

“Unfortunately, we had to abandon the study because we found that the transmitter apparatus was interfering with locomotion. If the belt was too tight, it caused abrasion. If it was too loose it slid down around the legs and left the frog immobilized and vulnerable to predation,” he said.

The frog pants, he says, seem to offer a solution to this conundrum. 

…

Lea Randall, a Calgary Zoo and Wilder Institute ecologist who specializes in amphibians and reptiles, ran into similar obstacles while trying to track northern leopard frogs at a reintroduction site in B.C. 

Like the Stanford researchers, her team experimented with several different designs before landing on one that worked — a belt-like attachment with some “very stylish” smooth glass beads to prevent abrasion. 

“Unfortunately, due to the weight of the radio transmitters at the time we couldn’t study smaller individuals,” she said. 

“We didn’t use leg straps, but I can see the advantages of that to help keep the transmitters in place. The creative thinking and problem solving that goes into developing these kinds of studies always amazes me.”

…

Finally, frogs may be smarter than we think, from Goodyear’s June 13, 2023 article,

When it comes to animal cognition and behaviour, Pašukonis says frogs are understudied —  and he believes, underestimated — compared to birds and mammals.

The poisonous rainforest frogs, he says, may be only a few centimetres in size, but when they breed, they carry their tadpoles between 200 to 300 metres across the rainforest to find them the perfect puddle to grow in.

Then they turn right around, and make their way home again. 

“How could a little frog — frogs typically are not thought to be very smart — learn to navigate on such a big scale? And how do they find their way around more on a fundamental scientific level?” Pašukonis said.

“We’re uncovering that overall amphibians, for example, might be smarter or have more complicated cognitive abilities than we thought.”

Here’s a link to and a citation for the paper published by Pašukonis and his colleagues,

Contrasting parental roles shape sex differences in poison frog space use but not navigational performance by Andrius Pašukonis, Shirley Jennifer Serrano-Rojas, Marie-Therese Fischer, Matthias-Claudio Loretto, Daniel A Shaykevich, Bibiana Rojas, Max Ringler, Alexandre B Roland, Alejandro Marcillo-Lara, Eva Ringler, Camilo Rodríguez, Luis A Coloma, Lauren A O’Connell. eLife DOI: https://doi.org/10.7554/eLife.80483 Version of Record Published: Nov 15, 2022

This paper appears to be open access.

Canadian Science Policy Centre panel on Sept. 6, 2023 [date changed to October 4, 2023]: Science, technology and innovation (STI) between Brazil and Canada plus a quantum panel on Sept. 13, 2023

Leave a reply

In an August 17, 2023 Canadian Science Policy Centre (CSPC) newsletter (received via email), they’ve announced a panel about science and technology opportunities with a country we don’t usually talk about much in that context (nice to see a broader, not the US and not a European or Commonwealth country, approach being taken),

Canada-Brazil Cooperation and Collaboration in STI [Science, Technology, and Innovation]

This virtual panel aims to discuss the ongoing Science, Technology, and Innovation (STI) cooperation between Brazil and Canada, along with the potential for furthering this relationship. The focus will encompass strategic areas of contact, ongoing projects, and scholarship opportunities. It is pertinent to reflect on the science diplomacy efforts of each country and their reciprocal influence. Additionally, the panel aims to explore how Canada engages with developing countries in terms of STI.

Click the button below to register for the upcoming virtual panel!

Register Here

Date: Sept. 6 [2023] October 4, 2023
Time: 1:00 pm EDT

Here are the speakers (from the CSPC’s Canada-Brazil Cooperation and Collaboration in STI event page),

Fernanda de Negri
Moderator
Director of Studies and Sectoral Policies of Innovation, Regulation and Infrastructure at the Institute for Applied Economic Research (IPEA), Brazil
See Bio

Alejandro Adem
President of Natural Sciences and Engineering Research Council of Canada – NSERC
See Bio

Ambassador Emmanuel Kamarianakis
Canadian Embassy in Canada
See Bio

Ambassador Ademar Seabra da Cruz Jr.
Ministry of Foreign Affairs, Brazil
See Bio

If you haven’t gotten your fill of virtual science policy panels yet, there’s this one on quantum technologies, from the August 17, 2023 Canadian Science Policy Centre (CSPC) newsletter,

Canada’s Quantum Strategy and International Collaboration

Countries are investing heavily in quantum computing and other quantum technologies. As Canada has recently released its Quantum Strategy [Note: There is also report on Quantum Technologies expected from the Canadian Council of Academies, no release date yet], this is an opportunity to foster further international collaborations. Panelists will discuss the opportunities and challenges Canada will be facing and what this could mean for Canada’s leadership in quantum research and the development of quantum technologies.

Click the button below to register for the upcoming virtual panel!

Register Here

Date: Sep 13 [2023]
Time: 1:00 pm EDT

Here’s some information about the panel participants, from the CSPC’s Canada’s Quantum Strategy and International Collaboration event page,

Dr. Sarah Burke
Associate Professor, University of British Columbia
See Bio

Dr. Aimee K. Gunther
Deputy Director, Quantum Sensors Challenge Program, National Research Council Canada
See Bio

Prof. Andrea Damascelli
Scientific Director, Stewart Blusson Quantum Matter Institute | Professor, Physics and Astronomy | Canada Research Chair in the Electronic Structure of Quantum Materials
See Bio

Nick Werstiuk
CEO, Quantum Valley Ideas Lab
See Bio

Eric Miller
Fellow, Canadian Global Affairs Institute
See Bio

Ms. Alexandra Daoud
Moderator
Vice President, Intellectual Property at Anyon Systems
See Bio

Interestingly, the moderator, Alexandra Daoud, is a patent agent.

As for the Council of Canadian Academies, you can find out about the proposed report on Quantum Technologies here.

Nanoparticle drug delivery could reduce rejection rates for corneal transplants

Leave a reply

I like pictures of happy researchers and, as these pictures go, the researchers seem pretty relaxed,

Caption: Qingguo Xu, D.Phil., associate professor of pharmaceutics and ophthalmology at VCU School of Pharmacy, (right) in the lab with Tuo Meng, Ph.D., (left) and Vineet Kulkarni. (School of Pharmacy) Credit: VCU School of Pharmacy

A March 23, 2023 Virginia Commonwealth University (VCU) news release (also on EurekAlert) announces work into making corneal transplants more successful, Note: A link has been removed,

Corneal transplants can be the last step to returning clear vision to many patients suffering from eye disease. Each year, approximately 80,000 corneal transplantations take place in the U.S. Worldwide, more than 184,000 corneal transplantation surgeries are performed annually. 

However, rejection rates for the corneal grafts can be as high as 10%. This is largely due to poor patient compliance to the medications, which require frequent administrations of topical eyedrops over a long period of time. 

This becomes especially acute when patients show signs of early rejection of the transplanted corneas. When this occurs, patients need to apply topical eyedrops [sic] hourly to rescue the corneal grafts from failure. 

The tedious process of eyedrop [sic] dosing causes a tremendous burden for patients. The resulting noncompliance to medication treatment can lead to even higher graft-rejection rates. 

Research led by a team at Virginia Commonwealth University may make the corneal grafts more successful by using nanoparticles to encapsulate the medication. The novel approach could significantly improve patient compliance, according to a paper recently published in Science Advances, “Six-month effective treatment of corneal graft rejection.”

Each nanoparticle encapsulates a drug called dexamethasone sodium phosphate, one of the most commonly used corticosteroids for various ocular diseases treatment such as ocular inflammation, non-infectious uveitis, macular edema and corneal neovascularization. By using the nanoparticles to control the release of the medicine over time, patients would require only one injection right after the corneal transplantation surgery without the frequent eye drops. Our studies have shown that using this method the medication maintains its efficacy for six months on a corneal graft rejection model. 

In addition, because the medicine is released slowly and directly where it is most needed, the approach requires much lower doses than current standard eyedrop treatment while providing better efficacy and safety profiles.

Qingguo Xu, D.Phil., the principal investigator of this project and an associate professor of pharmaceutics and ophthalmology at VCU School of Pharmacy, collaborated with Justin Hanes, Ph.D., the Lewis J. Ort professor of ophthalmology at Johns Hopkins University.

Xu said, “To improve patient compliance and treatment efficacy, we developed a tiny nanoparticle (around 200 nanometers) that in animal studies enables the release of the drug up to six months after a single subconjunctival injection along the eyeball.”

Tuo Meng, Ph.D., who worked on the project as a doctoral student at VCU and is the first author of this paper, said: “In our preclinical corneal graft rejection model, the single dosing of the nanoparticle successfully prevented corneal graft rejection for six months.” 

More importantly, the nanoparticle approach reversed signs of early rejection and maintained corneal grafts for six months without rejection. 

This work was supported by the National Eye Institute, National Institutes of Health, through the R01 grant R01EY027827. 

Xu’s lab focuses on developing nanotherapeutics for safer and more effective treatment of various eye diseases.

Here’s a link to and a citation for the paper,

Six-month effective treatment of corneal graft rejection by Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M.R., Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A. Rudek, Woon Chow, Walter Stark, Laura M. Ensign, Justin Hanes, and Qingguo Xu. Science Advances 22 Mar 2023 Vol 9, Issue 12 DOI: 10.1126/sciadv.adf4608

This paper is open access.

Nanobiotics and artificial intelligence (AI)

Leave a reply

Antibiotics at the nanoscale = nanobiotics. For a more complete explanation, there’s this (Note: the video runs a little longer than most of the others embedded on this blog),

Before pushing further into this research, a note about antibiotic resistance. In a sense, we’ve created the problem we (those scientists in particular) are trying to solve.

Antibiotics and cleaning products kill 99.9% of the bacteria, leaving 0.1% that are immune. As so many living things on earth do, bacteria reproduce. Now, a new antibiotic is needed and discovered; it too kills 99.9% of the bacteria. The 0.1% left are immune to two antibiotics. And,so it goes.

As the scientists have made clear, we’re running out of options using standard methods and they’re hoping this ‘nanoparticle approach’ as described in a June 5, 2023 news item on Nanowerk will work, Note: A link has been removed,

Identifying whether and how a nanoparticle and protein will bind with one another is an important step toward being able to design antibiotics and antivirals on demand, and a computer model developed at the University of Michigan can do it.

The new tool could help find ways to stop antibiotic-resistant infections and new viruses—and aid in the design of nanoparticles for different purposes.

“Just in 2019, the number of people who died of antimicrobial resistance was 4.95 million. Even before COVID, which worsened the problem, studies showed that by 2050, the number of deaths by antibiotic resistance will be 10 million,” said Angela Violi, an Arthur F. Thurnau Professor of mechanical engineering, and corresponding author of the study that made the cover of Nature Computational Science (“Domain-agnostic predictions of nanoscale interactions in proteins and nanoparticles”).

In my ideal scenario, 20 or 30 years from now, I would like—given any superbug—to be able to quickly produce the best nanoparticles that can treat it.”

…

A June 5, 2023 University of Michigan news release (also on EurekAlert), which originated the news item, provides more technical details, Note: A link has been removed,

Much of the work within cells is done by proteins. Interaction sites on their surfaces can stitch molecules together, break them apart and perform other modifications—opening doorways into cells, breaking sugars down to release energy, building structures to support groups of cells and more. If we could design medicines that target crucial proteins in bacteria and viruses without harming our own cells, that would enable humans to fight new and changing diseases quickly.

The new [computer] model, named NeCLAS [NeCLAS (Nanoparticle-Computed Ligand Affinity Scoring)], uses machine learning—the AI technique that powers the virtual assistant on your smartphone and ChatGPT. But instead of learning to process language, it absorbs structural models of proteins and their known interaction sites. From this information, it learns to extrapolate how proteins and nanoparticles might interact, predict binding sites and the likelihood of binding between them—as well as predicting interactions between two proteins or two nanoparticles.

“Other models exist, but ours is the best for predicting interactions between proteins and nanoparticles,” said Paolo Elvati, U-M associate research scientist in mechanical engineering.

AlphaFold, for example, is a widely used tool for predicting the 3D structure of a protein based on its building blocks, called amino acids. While this capacity is crucial, this is only the beginning: Discovering how these proteins assemble into larger structures and designing practical nanoscale systems are the next steps.

“That’s where NeCLAS comes in,” said Jacob Saldinger, U-M doctoral student in chemical engineering and first author of the study. “It goes beyond AlphaFold by showing how nanostructures will interact with one another, and it’s not limited to proteins. This enables researchers to understand the potential applications of nanoparticles and optimize their designs.”

The team tested three case studies for which they had additional data: 

  • Molecular tweezers, in which a molecule binds to a particular site on another molecule. This approach can stop harmful biological processes, such as the aggregation of protein plaques in diseases of the brain like Alzheimer’s.
  • How graphene quantum dots break up the biofilm produced by staph bacteria. These nanoparticles are flakes of carbon, no more than a few atomic layers thick and 0.0001 millimeters to a side. Breaking up biofilms is likely a crucial tool in fighting antibiotic-resistant infections—including the superbug methicillin-resistant Staphylococcus aureus (MRSA), commonly acquired at hospitals.
  • Whether graphene quantum dots would disperse in water, demonstrating the model’s ability to predict nanoparticle-nanoparticle binding even though it had been trained exclusively on protein-protein data.

While many protein-protein models set amino acids as the smallest unit that the model must consider, this doesn’t work for nanoparticles. Instead, the team set the size of that smallest feature to be roughly the size of the amino acid but then let the computer model decide where the boundaries between these minimum features were. The result is representations of proteins and nanoparticles that look a bit like collections of interconnected beads, providing more flexibility in exploring small scale interactions.

“Besides being more general, NeCLAS also uses way less training data than AlphaFold. We only have 21 nanoparticles to look at, so we have to use protein data in a clever way,” said Matt Raymond, U-M doctoral student in electrical and computer engineering and study co-author.  

Next, the team intends to explore other biofilms and microorganisms, including viruses.

The Nature Computational Science study was funded by the University of Michigan Blue Sky Initiative, the Army Research Office and the National Science Foundation. 

Here’s a link to and a citation for the paper,

Domain-agnostic predictions of nanoscale interactions in proteins and nanoparticles by Jacob Charles Saldinger, Matt Raymond, Paolo Elvati & Angela Violi. Nature Computational Science volume 3, pages 393–402 (2023) DOI: https://doi.org/10.1038/s43588-023-00438-x Published: 01 May 2023 Issue Date: May 2023

This paper is behind a paywall.

Ethical nanobiotechnology

Leave a reply

This paper on ethics (aside: I have a few comments after the news release and citation) comes from the US Pacific Northwest National Laboratory (PNNL) according to a July 12, 2023 news item on phys.org,

Prosthetics moved by thoughts. Targeted treatments for aggressive brain cancer. Soldiers with enhanced vision or bionic ears. These powerful technologies sound like science fiction, but they’re becoming possible thanks to nanoparticles.

“In medicine and other biological settings, nanotechnology is amazing and helpful, but it could be harmful if used improperly,” said Pacific Northwest National Laboratory (PNNL) chemist Ashley Bradley, part of a team of researchers who conducted a comprehensive survey of nanobiotechnology applications and policies.

Their research, available in Health Security, works to sum up the very large, active field of nanotechnology in biology applications, draw attention to regulatory gaps, and offer areas for further consideration.

…

A July 12, 2023 PNNL news release (also on EurekAlert), which originated the news item, delves further into the topic, Note: A link has been removed,

“In our research, we learned there aren’t many global regulations yet,” said Bradley. “And we need to create a common set of rules to figure out the ethical boundaries.”

Nanoparticles, big differences

Nanoparticles are clusters of molecules with different properties than large amounts of the same substances. In medicine and other biology applications, these properties allow nanoparticles to act as the packaging that delivers treatments through cell walls and the difficult to cross blood-brain barrier.

“You can think of the nanoparticles a little bit like the plastic around shredded cheese,” said PNNL chemist Kristin Omberg. “It makes it possible to get something perishable directly where you want it, but afterwards you’ve got to deal with a whole lot of substance where it wasn’t before.”

Unfortunately, dealing with nanoparticles in new places isn’t straightforward. Carbon is pencil lead, nano carbon conducts electricity. The same material may have different properties at the nanoscale, but most countries still regulate it the same as bulk material, if the material is regulated at all.

For example, zinc oxide, a material that was stable and unreactive as a pigment in white paint, is now accumulating in oceans when used as nanoparticles in sunscreen, warranting a call to create alternative reef-safe sunscreens. And although fats and lipids aren’t regulated, the researchers suggest which agencies could weigh in on regulations were fats to become after-treatment byproducts.

The article also inventories national and international agencies, organizations, and governing bodies with an interest in understanding how nanoparticles break down or react in a living organism and the environmental life cycle of a nanoparticle. Because nanobiotechnology spans materials science, biology, medicine, environmental science, and tech, these disparate research and regulatory disciplines must come together, often for the first time—to fully understand the impact on humans and the environment.

Dual use: Good for us, bad for us

Like other quickly growing fields, there’s a time lag between the promise of new advances and the possibilities of unintended uses.

“There were so many more applications than we thought there were,” said Bradley, who collected exciting nanobio examples such as Alzheimer’s treatment, permanent contact lenses, organ replacement, and enhanced muscle recovery, among others.

The article also highlights concerns about crossing the blood-brain barrier, thought-initiated control of computers, and nano-enabled DNA editing where the researchers suggest more caution, questioning, and attention could be warranted. This attention spans everything from deep fundamental research and regulations all the way to what Omberg called “the equivalent of tattoo removal” if home-DNA splicing attempts go south.

The researchers draw parallels to more established fields such as synthetic bio and pharmacology, which offer lessons to be learned from current concerns such as the unintended consequences of fentanyl and opioids. They believe these fields also offer examples of innovative coordination between science and ethics, such as synthetic bio’s IGEM [The International Genetically Engineered Machine competition]—student competition, to think about not just how to create, but also to shape the use and control of new technologies.

Omberg said unusually enthusiastic early reviewers of the article contributed even more potential uses and concerns, demonstrating that experts in many fields recognize ethical nanobiotechnology is an issue to get in front of. “This is a train that’s going. It will be sad if 10 years from now, we haven’t figured how to talk about it.”

Funding for the team’s research was supported by PNNL’s Biorisk Beyond the List National Security Directorate Objective.

Here’s a link to and a citation for the paper,

The Promise of Emergent Nanobiotechnologies for In Vivo Applications and Implications for Safety and Security by Anne M. Arnold, Ashley M. Bradley, Karen L. Taylor, Zachary C. Kennedy, and Kristin M. Omberg. Health Security.Oct 2022.408-423.Published in Volume: 20 Issue 5: October 17, 2022 DOI: https://doi.org/10.1089/hs.2022.0014 Published Online:17 Oct 2022

This paper is open access.

You can find out more about IGEM (The International Genetically Engineered Machine competition) here.

Comments (brief)

It seems a little odd that the news release (“Prosthetics moved by thoughts …”) and the paper both reference neurotechnology without ever mentioning it by name. Here’s the reference from the paper, Note: Links have been removed,

Nanoparticles May Be Developed to Facilitate Cognitive Enhancements

The development and implementation of NPs that enhance cognitive function has yet to be realized. However, recent advances on the micro- and macro-level with neural–machine interfacing provide the building blocks necessary to develop this technology on the nanoscale. A noninvasive brain–computer interface to control a robotic arm was developed by teams at 2 universities.157 A US-based company, Neuralink, [emphasis mine] is at the forefront of implementing implantable, intracortical microelectrodes that provide an interface between the human brain and technology.158,159 Utilization of intracortical microelectrodes may ultimately provide thought-initiated access and control of computers and mobile devices, and possibly expand cognitive function by accessing underutilized areas of the brain.158

Neuralink (founded by Elon Musk) is controversial for its animal testing practices. You can find out more in Björn Ólafsson’s May 30, 2023 article for Sentient Media.

The focus on nanoparticles as the key factor in the various technologies and applications mentioned seems narrow but necessary given the breadth of topics covered in the paper as the authors themselves note in the paper’s abstract,

… In this article, while not comprehensive, we attempt to illustrate the breadth and promise of bionanotechnology developments, and how they may present future safety and security challenges. Specifically, we address current advancements to streamline the development of engineered NPs for in vivo applications and provide discussion on nano–bio interactions, NP in vivo delivery, nanoenhancement of human performance, nanomedicine, and the impacts of NPs on human health and the environment.

…

They have a good overview of the history and discussions about nanotechnology risks and regulation. It’s international in scope with a heavy emphasis on US efforts, as one would expect.

For anyone who’s interested in the neurotechnology end of things, I’ve got a July 17, 2023 commentary “Unveiling the Neurotechnology Landscape: Scientific Advancements, Innovations and Major Trends—a UNESCO report.” The report was launched July 13, 2023 during UNESCO’s Global dialogue on the ethics of neurotechnology (see my July 7, 2023 posting about the then upcoming dialogue for links to more UNESCO information). Both the July 17 and July 7, 2023 postings included additional information about Neuralink.